Health Care: Drugs

Navidea Biopharmaceuticals Inc (NAVB: )

$1.38 n/a | n/a%
04/29/16 - 04:03 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 13.25M 6.27M 1.13M 78.74K
Cost of Sales 690.38K 241.71K 332.81K 0.00
Gross Operating Profit 12.56M 6.03M 797.82K 78.74K
Selling, General, and Administrative Expenses 17.26M 15.54M 15.53M 11.18M
Research & Development 12.79M 16.78M 23.71M 16.89M
Operating Income before D & A (EBITDA) -17.49M -26.29M -38.44M -27.99M
Depreciation & Amortization 1.06M 1.34M 1.17M 744.74K
Interest Income 0.00 16.10K 18.84K 25.04K
Other Income - Net -3.03M -3.88M -1.50M -26.61K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -21.88M -32.02M -41.09M -28.74M
Interest Expense 6.87M 3.71M 2.78M 1.17M
Pre-Tax Income -28.76M -35.73M -43.87M -29.90M
Income Taxes -436.05K 0.00 0.00 0.00
Minority Interest -855.00 0.00 0.00 0.00
Net Income From Continuing Operations -28.32M -35.73M -42.70M -29.16M
Net Income From Discontinued Operations 758.61K 0.00 0.00 0.00
Net Income From Total Operations -27.56M -35.73M -42.70M -29.16M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -27.56M -35.73M -42.70M -29.16M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-28.32M -35.73M -42.70M -29.16M
Preferred Dividends
Net Income Available To Common -28.37M -35.73M -42.70M -29.20M
Basic EPS from Continuing Ops. -0.19 -0.24 -0.35 -0.29
Basic EPS from Discontinued Ops. 0.01 0.00 0.00 0.00
Basic EPS from Total Operations -0.18 -0.24 -0.35 -0.29
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.18 -0.24 -0.35 -0.29
Basic Normalized Net Income/Share -0.19 -0.24 -0.35 -0.29
EPS fr Continuing Ops. -0.19 -0.24 -0.35 -0.29
EPS fr Discontinued Ops 0.01 0.00 0.00 0.00
EPS fr Total Ops. -0.18 -0.24 -0.35 -0.29
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.18 -0.24 -0.35 -0.29
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.19 -0.24 -0.35 -0.29
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with NAVB

Latest NAVB Headlines from TheStreet

More Financial News for NAVB

Press Releases for NAVB

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter